Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Gold, Herman K., MD.
Recruitment status was  Recruiting
Study NCT00476944   Information provided by Gold, Herman K., MD

First Received on May 18, 2007.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Artery Disease
Additional conditions recognized in this trial
Coronary Disease
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Heart Diseases
Vascular Diseases
Additional drug interventions recognized in this trial
Bivalirudin
Heparin
More general drug interventions related to this trial
Anticoagulants
Antithrombins
Cardiovascular Agents
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Serine Proteinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Gold, Herman K., MD
The Medicines Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services